Can Fusobacterium species cause infective endocarditis?

Can Fusobacterium Cause Endocarditis?

Yes, Fusobacterium species can definitively cause infective endocarditis, though it is rare. This anaerobic Gram-negative bacillus, normally found in the oropharynx and gastrointestinal tract, represents an uncommon but serious cause of IE that clinicians must recognize.

Clinical Characteristics

Fusobacterium IE has distinct features that differentiate it from more common causes:

• Demographics: Predominantly affects younger males (median age 48 years, 85.7% male) 1
• Predisposing factors: Poor dental hygiene or recent dental procedures in 47.6% of cases 1
• Valve involvement: Mitral valve most commonly affected (44.4%), though can involve any valve 1
• Species: F. necrophorum (47.6%) and F. nucleatum (42.9%) are the most frequently isolated 1

Key Clinical Pitfall: Diagnostic Delay

The most critical challenge is delayed diagnosis. Fusobacterium requires specific anaerobic culture conditions, leading to delays in identification 2. Blood cultures may take up to one week to become positive 3. This organism should be suspected particularly in:

• Previously healthy patients without preexisting cardiac disease 4
• Patients with recent dental work or poor oral hygiene 1, 3
• Young to middle-aged adults with unexplained fever and sepsis following head/neck infections 2

Clinical Presentation

The presentation is typically severe:

• Universal findings: Fever and sepsis in nearly all cases 1
• Embolic phenomena: Occur in 81% of patients 1
• Systemic complications: Can include intracranial abscesses 2, liver abscesses 4, and features of Lemierre's syndrome
• Vegetation characteristics: Often large vegetations similar to those seen with HACEK organisms 5

Treatment Approach

While major guidelines 6, 7, 8 do not specifically address Fusobacterium IE, treatment follows principles for anaerobic Gram-negative organisms:

Antibiotic therapy:

• Metronidazole was used in 61.9% of reported cases 1
• Ampicillin-sulbactam has been successfully used for 6-week courses 3
• Important: Some strains show metronidazole resistance 9, requiring susceptibility-guided therapy
• Duration: Minimum 6 weeks, consistent with guidelines for Gram-negative IE 7

Surgical management:

• Required in 23.8% of cases 1
• Consider early surgical consultation given the high rate of embolic complications (81%) 1
• Indications follow standard IE surgical criteria: heart failure, uncontrolled infection, prevention of embolism 8

Prognosis

The mortality appears lower than other anaerobic IE:

• All-cause mortality: 9.5% 1
• Infection-attributable mortality: 9.5% 1
• This contrasts favorably with other Gram-negative bacillary endocarditis (mortality 60-80%) 7

However, one case series reported death despite appropriate therapy 9, emphasizing the need for aggressive management.

Clinical Algorithm

1. Suspect Fusobacterium IE when:

   • Young/middle-aged patient without prior cardiac disease
   • Recent dental procedure or poor oral hygiene
   • Fever, sepsis, and embolic phenomena
   • Blood cultures initially negative or delayed growth

2. Diagnostic approach:

   • Obtain multiple blood culture sets with prolonged incubation for anaerobes
   • Transesophageal echocardiography to identify vegetations
   • Assess for metastatic foci (brain, liver, lungs)

3. Treatment:

   • Initiate empiric broad-spectrum coverage including anaerobic activity
   • Tailor to susceptibilities once organism identified
   • Minimum 6-week course
   • Early cardiac surgery consultation if large vegetations (>10mm), embolic events, or hemodynamic compromise

4. Source control:

   • Dental evaluation and treatment of oral disease 10
   • Address any head/neck infection source

The oral cavity is the likely portal of entry 9, making dental hygiene and source control essential components of management alongside antimicrobial therapy.